PDRN Cyclic Peptide Rod PRO harnesses high-activity Sodium DNA constrained into an ordered supramolecular rod-like self-assembly complex, integrated with patented transdermal cyclic peptides to overcome the historic challenge of large nucleic acid skin penetration.
This formulation efficiently delivers deep revitalizing signals to basal cells, supporting cellular metabolic vitality, natural nucleic acid replenishment, and barrier resilience against environmental stressors. It notably improves dermal firmness, elasticity, and plump moisture retention, making it ideal for prestige anti-aging serums, intensive repair essences, and rejuvenating sheet masks.
Cell Regeneration Data
PDRN polydeoxyribonucleotide tissue microcirculation and cell vitality test data.
RAW MATERIAL TECHNICAL & REGULATORY DOSSIER
Comprehensive Technical, Quality Specification, and Regulatory Dossier for R&D Formulators, Procurement, and Product Managers
📊
Biotechnology Mechanism & Scientific Evidence
Authoritative Brochure Technical Diagram · Molecular Model · Transdermal & Efficacy Mechanism
Mechanism DiagramSupramolecular rod assembly of PDRN bound with transdermal cyclic peptides: cutaneous delivery and absorption data.
🔬
Formulation R&D Engineer Guide (R&D Technical Dossier)
Formulation Application · Physicochemical Parameters · Stability & Compatibility
| INCI Name (CN) |
、Decapeptide-4、1,2-1,2-Hexanediol, Aqua |
INCI Name (EN) |
Sodium DNA, Decapeptide-4, 1,2-Hexanediol, Aqua |
| CAS No. |
9007-49-2 / 917094-11-2 / 6920-22-5 / 7732-18-5 |
Recommended Dosage |
0.3% - 3.0%（ active 0.5% - 1.5%） |
| Optimal pH Range |
6.0 - 7.5 |
Thermal Processing |
Add below 40°C during final blending stage |
| Appearance & Odor |
Colorless to pale opalescent viscous liquid, odorless |
Solubility & Method |
Fully miscible in aqueous systems and essence bases |
💡 Compatibility Guidelines & Precautions: Compatible with hyaluronic acid, peptides, and niacinamide; avoid high concentrations of polyvalent metal ions (e.g., Fe3+, Al3+)
📦
Procurement & Compliance Dossier (Procurement & Compliance)
NMPA Code · MOQ · Sampling Support · Certificate of Analysis
| NMPA Submission Code |
✓ 219361-00075-7512 |
Supply Packaging |
1kg/bottle, 5kg/drum, 20kg/sealed container |
| Minimum Order Quantity (MOQ) |
1 kg (In Stock) |
Delivery Lead Time |
Dispatched within 24-48 hours |
| Storage Conditions |
Store sealed at 2-8°C, protected from light |
Shelf Life (Shelf Life) |
24 Months |
| R&D Sample Support |
Complimentary 30g trial sample available upon request |
Quality Documentation |
Batch COA, MSDS, TDS, HPLC Purity Certificate |
💡
Product Planning & Marketing Highlights (Marketing Highlights)
Core Mechanism · Efficacy Claims · Recommended Formats · Scientific Backing
🧬 Core Bio-Tech Barrier & Mechanism of Action:
Salmon polydeoxyribonucleotide (PDRN) combined with cyclic peptides acts as an adenosine A2A receptor agonist, initiating salvage pathways to supply nucleotides for cellular repair, reducing pro-inflammatory cytokines (IL-6, TNF-alpha), and boosting fibroblast VEGF and collagen secretion.
✨ Key Selling Point Keywords:
🏷️ Intensive Barrier Repair🏷️ Soothing Facial Redness🏷️ Repairing Dry & Fragile Skin🏷️ Plumping & Elastic Firmness🏷️ Synergistic Anti-Wrinkle Defense
🧴 Recommended Product Formats & Categories:
Post-procedure soothing serums, barrier rescue creams, transdermal essence sticks, targeted micro-infusion liquids
📜 Patented Technologies & Scientific Backing:
Patent-pending cyclic peptide delivery carrier for nucleic acid bioactive macromolecules
⚖️
Regulatory Compliance & Peer-to-Peer Disclaimer
Regulatory & Professional Compliance Statement:
1. The raw material characteristics and experimental data (including cytological studies, mechanism diagrams, and literature citations) presented on this webpage are intended exclusively for technical discussion and formulation R&D reference by cosmetic brand formulators, R&D engineers, product planners, and academic research institutions. They do not constitute finished consumer cosmetic efficacy claims or commercial warranties.
2. Pursuant to the Regulations on the Supervision and Administration of Cosmetics, Standards for Cosmetic Efficacy Claim Evaluation, and relevant global cosmetic regulatory frameworks, cosmetic brand enterprises utilizing this raw material shall be solely responsible for the safety, stability, and efficacy claims of their finished consumer products, and shall independently complete efficacy evaluations and regulatory filings/registrations with the competent health authorities prior to commercial launch. Conclusions from in-vitro or cellular studies shall not be directly extrapolated as consumer claims.
3. Mellgen Biotech assumes no joint or indirect liability for any claims or regulatory non-compliance arising from improper customer formulation, unauthorized off-label claims, or unverified applications.
